Your browser doesn't support javascript.
loading
Improvement in Inhalation Properties of Theophylline and Levofloxacin by Co-Amorphization and Enhancement in Its Stability by Addition of Amino Acid as a Third Component.
Ueda, Hiroshi; Hirakawa, Yuya; Miyano, Tetsuya; Nakayama, Yuzuki; Hatanaka, Yuta; Uchiyama, Hiromasa; Tozuka, Yuichi; Kadota, Kazunori.
Afiliação
  • Ueda H; Analysis and Evaluation Laboratory, Shionogi & Co., Ltd., Osaka 561-0825, Japan.
  • Hirakawa Y; Analysis and Evaluation Laboratory, Shionogi & Co., Ltd., Osaka 561-0825, Japan.
  • Miyano T; Laboratory for Medicinal Chemistry Research, Shionogi & Co., Ltd., Osaka 561-0825, Japan.
  • Nakayama Y; Department of Formulation Design and Pharmaceutical Technology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Osaka 569-1094, Japan.
  • Hatanaka Y; Department of Formulation Design and Pharmaceutical Technology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Osaka 569-1094, Japan.
  • Uchiyama H; Department of Formulation Design and Pharmaceutical Technology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Osaka 569-1094, Japan.
  • Tozuka Y; Department of Formulation Design and Pharmaceutical Technology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Osaka 569-1094, Japan.
  • Kadota K; Department of Formulation Design and Pharmaceutical Technology, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Osaka 569-1094, Japan.
Mol Pharm ; 20(12): 6368-6379, 2023 Dec 04.
Article em En | MEDLINE | ID: mdl-37942959
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Teofilina / Aminoácidos Idioma: En Revista: Mol Pharm Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Teofilina / Aminoácidos Idioma: En Revista: Mol Pharm Ano de publicação: 2023 Tipo de documento: Article